Review of the Federal Bureau of Prisons' Pharmaceutical Drug Costs and Procurement
- NARA ID
- review-federal-bureau-prisons-pharmaceutical-drug-costs-and-procurement
- Source
- oig-doj
- Collection
- DOJ OIG — Federal Bureau of Prisons
- Agency
- U.S. DOJ Office of the Inspector General
- Classification
- Inspection / Evaluation
- Released
- 2020-02-20
- Slug
- doj-oig-review-federal-bureau-prisons-pharmaceutical-drug-costs-and-procurement
- Indexed
- 2026-04-27 05:04:10
More from DOJ OIG — Federal Bureau of Prisons
- Audit of the Federal Bureau of Prisons’ Information Security Program Pursuant to the Federal Information Security Modernization Act of 2014, Fiscal Year 2022
- Audit of the Federal Bureau of Prisons' Furlough Program
- Management Advisory Memorandum: Notification of Concerns Resulting from Multiple Office of the Inspector General Reviews Related to the Federal Bureau of Prisons Strategy for its Medical Services Contracts
- Investigation and Review of the Federal Bureau of Prisons’ Custody, Care, and Supervision of Jeffrey Epstein at the Metropolitan Correctional Center in New York, New York
- Review of the Federal Bureau of Prisons' Untimely Releases of Inmates
- Notification of Concerns Regarding Conditions at Federal Correctional Institution Terre Haute
Browse all 158 documents in DOJ OIG — Federal Bureau of Prisons →
About the DOJ OIG — Federal Bureau of Prisons collection
U.S. DOJ Office of the Inspector General reports (audits, investigations, evaluations, and reviews) concerning Federal Bureau of Prisons.